The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.

Analyst Naz Rahman of Maxim Group reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target of ...

Viking Therapeutics (VKTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Viking Therapeutics has announced positive results from its Phase Ib trial of VK0214 in patients with X-linked ...

Baron Health Care Fund highlighted stocks like Viking Therapeutics, Inc. (NASDAQ:VKTX), in the second quarter 2024 investor ...

Alger Small Cap Growth Fund highlighted stocks like Viking Therapeutics, Inc. (NASDAQ:VKTX), in the first quarter 2024 ...

These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.

Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies ...

Two more murals — and seven decorated utility boxes — are being installed by local artists along the First Avenue corridor in ...

Repsol (ETR: REP) (OTC: REPYY) is under scrutiny following its third-quarter 2024 trading update, with a weaker refining ...

S&P 500, US Small Cap 2000, iShares Russell 2000 ETF, NASDAQ Composite. Read Declan Fallon's latest article on Investing.com Australia.